Crossmark

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family

Crossref DOI link: https://doi.org/10.1186/s13195-017-0334-y

Published Online: 2018-01-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sieben, Anne

Van Mossevelde, Sara

Wauters, Eline

Engelborghs, Sebastiaan

van der Zee, Julie

Van Langenhove, Tim

Santens, Patrick

Praet, Marleen

Boon, Paul

Miatton, Marijke

Van Hoecke, Sofie

Vandenbulcke, Mathieu

Vandenberghe, Rik

Cras, Patrick

Cruts, Marc

De Deyn, Peter Paul

Van Broeckhoven, Christine

Martin, Jean-Jacques https://orcid.org/0000-0001-8493-7180
More Information

Article History

Received: 27 July 2017

Accepted: 20 December 2017

First Online: 22 January 2018

Ethics approval and consent to participate

: The local medical ethics committee of the University of Antwerp approved the research protocols for clinical, genetic, and neuropathological studies. The patients and/or their legal representatives consented to participation in this research.

: The patients and/or their legal representatives gave their consent for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.